OncoCyte Corp.
(NYSE Amex Equities : OCX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 8.72%21.456.3%$1116.52m
MDTMedtronic Plc 0.93%93.180.6%$608.53m
ABTAbbott Laboratories 0.66%92.240.8%$564.00m
TMOThermo Fisher Scientific, Inc. 1.69%365.851.0%$548.96m
DXCMDexCom, Inc. 1.78%407.358.2%$544.50m
BDXBecton, Dickinson & Co. 1.42%244.951.0%$513.39m
DHRDanaher Corp. 1.42%179.680.7%$458.12m
BSXBoston Scientific Corp. 0.31%35.391.0%$435.72m
ISRGIntuitive Surgical, Inc. 0.86%580.482.4%$376.03m
QDELQuidel Corp. 2.85%227.047.7%$372.79m
SYKStryker Corp. 0.11%184.051.3%$326.37m
BAXBaxter International, Inc. -0.13%87.201.8%$280.06m
ALGNAlign Technology, Inc. 2.22%279.936.4%$275.80m
EWEdwards Lifesciences Corp. 0.33%69.230.4%$224.11m
ZBHZimmer Biomet Holdings, Inc. 1.08%120.631.7%$213.14m

Company Profile

OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.